CAR T-Cell Therapy for Relapsed/Refractory Follicular Lymphoma

By News Health
5 hours Ago

(MedPage Today) — When it comes to relapsed/refractory follicular lymphoma, chimeric antigen receptor (CAR) T-cell therapy has become a go-to treatment for some patients, with its high end durable response rates, and lengthy survival outcomes…

Source link : https://www.medpagetoday.com/spotlight/follicular-lymphoma/115576

Author :

Publish date : 2025-05-14 16:16:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Mucus-Plugged Airways Linked to COPD Outcomes

Backup Drug Gains Footing for Resistant Hypertension

Norovirus vaccine pill protects against winter vomiting bug

Does It Matter if the U.S. Surgeon General Never Practiced Medicine?

EPA Announces Rollback for Some Biden-Era Limits on PFAS in Drinking Water

U.S. Overdose Deaths Fell 27% Last Year, but Remain Above Prepandemic Levels